The Evolution of Fluorescein into A Potential Theranostic Tool
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202501513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Konstantinos S Adamis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Crete, Voutes, Heraklion, Greece. Hauptthemen laut MEDLINE: Fluorescein, Fluorescent Dyes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Crete, General Secretariat for Research and Innovation of the Greek Ministry of Development and Investments, HORIZON EUROPE Marie Sklodowska-Curie Actions.
Abstract (Originalsprache)
Recent advances in drug discovery and development have been marked by the emergence of new modalities, including small molecule theranostic agents. While initial results from clinical trials have been promising, modern detectable inhibitors are still in an early stage of development. In this study, we present a strategy for chemically evolving a fluorescent imaging agent into a potent therapeutic entity, which not only retains its properties but also enhances its inhibition and detection applicability. By utilizing 15‐LOX‐1 as a model system, we leverage prior knowledge of its inhibitors to rationally functionalize fluorescein, enabling the targeted and highly efficient synthesis of over 20 derivatives across four different scaffolds. This approach ultimately led to the development of a potent, cell‐permeable inhibitor that effectively engages its target in live cells and enables real‐time visualization. These findings validate our new strategy for the development of small molecule diagnostic modulators, paving the way for application in other targets as well.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Crete, Voutes, Heraklion, Greece.
- Foundation for Research and Technology Hellas, Institute of Molecular Biology and Biotechnology, Heraklion, Greece.
- Division of Basic Sciences, School of Medicine, University of Crete, Voutes, Heraklion, Greece.
ORCID-Profile: Nikolaos Eleftheriadis, Constantinos G Neochoritis
Förderung
- University of Crete
- General Secretariat for Research and Innovation of the Greek Ministry of Development and Investments
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- Directorate-General for Research and Innovation
- Empeirikio Foundation
Zitieren
APA
Adamis, K. S., Georgoulakis, M., Angelonidis, I., Korovesis, D., Papadopoulos, C., Kapsalis, M., Tavernarakis, N., Eleftheriadis, N., & Neochoritis, C. G. (2025). The Evolution of Fluorescein into A Potential Theranostic Tool. Chemistry – A European Journal. https://doi.org/10.1002/chem.202501513
Vancouver
Adamis KS, Georgoulakis M, Angelonidis I, Korovesis D, Papadopoulos C, Kapsalis M, et al. The Evolution of Fluorescein into A Potential Theranostic Tool. Chemistry – A European Journal. 2025. doi:10.1002/chem.202501513
BibTeX
@article{Adamis2025,
author = {Adamis, Konstantinos S and Georgoulakis, Michail and Angelonidis, Ioannis and Korovesis, Dimitris and Papadopoulos, Christos and Kapsalis, Michael and Tavernarakis, Nektarios and Eleftheriadis, Nikolaos and Neochoritis, Constantinos G},
title = {The Evolution of Fluorescein into A Potential Theranostic Tool},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202501513}
}
EUVIMED